Financial Performance - The company reported a total revenue of 591 million yuan for the first half of 2025, representing a year-on-year increase of 9.7% [1] - The net profit attributable to shareholders reached 90.59 million yuan, up 32.84% year-on-year [1] - The gross margin improved to 35.37%, an increase of 12.47% compared to the previous year, while the net margin rose to 15.32%, up 21.09% [1] - The company’s operating cash flow per share decreased by 13.43% to 0.53 yuan [1] Financial Ratios - The company’s return on invested capital (ROIC) was 4.81% last year, indicating a relatively weak capital return [2] - The median ROIC since the company’s listing is 14.86%, with a significant drop to -2.39% in 2023 [2] - The company’s debt levels increased, with interest-bearing liabilities rising by 62.52% to 1.33 million yuan [1] Business Strategy and Market Outlook - The company is focusing on high-quality development in the agricultural chemical industry, with expectations of price increases for certain products due to improved market conditions [4] - The company aims to enhance its product development and market expansion efforts, particularly in the biopesticide sector, which is projected to grow significantly [5] - The company has established a specialized research team for biopesticides and is actively collaborating with universities and research institutions [5] Competitive Advantage - The company employs a differentiated strategy centered on formulation and has built a comprehensive distribution network across over 20 provinces [6] - The focus on technical marketing and customer-oriented solutions is designed to enhance product quality and service capabilities [6] - The company is committed to continuous improvement in product effectiveness and quality through optimized processes [6]

Financial Performance - The company reported a total operating revenue of 591 million yuan, an increase of 52.29 million yuan compared to the same period last year, achieving a year-on-year growth of 9.70% [1] - The net profit attributable to shareholders reached 90.59 million yuan, marking an increase of 22.39 million yuan from the previous year, with a year-on-year growth of 32.84% [1] - The net cash inflow from operating activities was 82.57 million yuan [1] Key Financial Ratios - The latest debt-to-asset ratio stands at 27.10%, ranking 7th among disclosed peers [3] - The gross profit margin is 35.37%, ranking 3rd among disclosed peers, with an increase of 2.30 percentage points from the previous quarter and a year-on-year increase of 3.92 percentage points [3] - The return on equity (ROE) is 7.44%, ranking 10th among disclosed peers, with a year-on-year increase of 1.59 percentage points [3] - The diluted earnings per share (EPS) is 0.58 yuan, ranking 11th among disclosed peers, with a year-on-year increase of 31.82% [3] - The total asset turnover ratio is 0.36 times, ranking 15th among disclosed peers, with a year-on-year increase of 1.41% [3] - The inventory turnover ratio is 3.25 times, ranking 10th among disclosed peers [3] Shareholder Information - The number of shareholders is 7,818, with the top ten shareholders holding a total of 115 million shares, accounting for 73.59% of the total share capital [3] - The largest shareholder is Zhejiang Xinhui Investment Co., Ltd., holding 54.5 million shares [3]

Core Insights - The company reported a total revenue of 591 million yuan for the first half of 2025, representing a year-on-year increase of 9.7% [1] - The net profit attributable to shareholders reached 90.59 million yuan, up 32.84% year-on-year [1] - The non-recurring net profit was 79.86 million yuan, showing a significant increase of 44.09% year-on-year [1] Financial Performance - In Q2 2025, the company achieved a quarterly revenue of 288 million yuan, which is a 10.02% increase compared to the same quarter last year [1] - The quarterly net profit attributable to shareholders for Q2 2025 was 48.87 million yuan, reflecting a 27.19% year-on-year growth [1] - The non-recurring net profit for Q2 2025 was 43.07 million yuan, marking a 38.76% increase year-on-year [1] Profitability and Efficiency - The company's debt ratio stands at 27.1% [1] - Investment income amounted to 563.23 thousand yuan, while financial expenses were recorded at -35.7 thousand yuan [1] - The gross profit margin is reported at 35.37%, which is an increase of 12.47% year-on-year [7] Earnings Metrics - Earnings per share (EPS) for the company is 0.58 yuan, up 31.81% year-on-year [7] - The operating cash flow per share is 0.53 yuan, showing a decrease of 13.43% year-on-year [7] - The return on assets (ROA) is 7.68%, reflecting a year-on-year increase of 30.61% [7]

Core Viewpoint - The report outlines the fundraising and usage status of Zhejiang Xinong Chemical Co., Ltd. (hereinafter referred to as "the Company") as of the first half of 2025, indicating that all raised funds have been utilized or permanently supplemented into working capital, with no remaining balance in the special accounts [1][2][8]. Fundraising Overview - The Company raised a total of RMB 429.90 million by issuing 30 million shares at RMB 14.33 per share, with net proceeds amounting to RMB 403.90 million after deducting underwriting fees and other expenses [1][2]. - The funds were deposited into designated bank accounts, including RMB 82.69 million in China Construction Bank, RMB 60 million in Agricultural Bank of China, and RMB 60 million in Industrial and Commercial Bank of China [1]. Fund Usage and Balance - As of June 30, 2025, the Company had utilized RMB 231.99 million in previous years and RMB 3.05 million in the current year, with a total interest income of RMB 41.92 million from bank deposits [2][3]. - The remaining balance of the raised funds, including interest and cash management income, was zero, with RMB 189.63 million permanently supplemented into working capital [2][3]. Fund Management - The Company established a special account system for managing the raised funds, signing tripartite and quadripartite supervision agreements with banks and the sponsor, Everbright Securities [3][5]. - All seven special accounts for the raised funds have been closed as of June 30, 2025, ensuring compliance with regulations [5][6]. Project Implementation and Adjustments - The Company has terminated the "Annual Production of 1,000 Tons of Pyrazole Ester and By-product 430 Tons of Sodium Chloride Project" due to external market conditions affecting project feasibility and expected returns [8][9]. - The remaining funds from terminated projects have been permanently supplemented into working capital to support daily operations [8][9]. Compliance and Verification - Everbright Securities conducted a compliance review and confirmed that the Company's management and usage of the raised funds adhered to relevant regulations, with no violations or misappropriations identified [8][9].

证券代码：002942 证券简称：新农股份 公告编号：2025-048 浙江新农化工股份有限公司 2025 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据《深圳证券交易所股票上市规则》《上市公司监管指引第 2 号——上市 公司募集资金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指引 第 1 号——主板上市公司规范运作》等有关法律法规和规范性文件的要求，浙江 新农化工股份有限公司（以下简称"公司"、"本公司"）2025 年半年度募集资 金存放与使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 本公司经中国证券监督管理委员会证监发行字[2018]1604 号文核准，由主承 销商光大证券股份有限公司通过深圳证券交易所系统采用网上按市值申购向社会 公众投资者直接定价发行的方式，向社会公开发行了人民币普通股(A 股)股票 3,000 万股，发行价为每股人民币 14.33 元，共计募集资金总额为人民币 42,990.00 万元，扣除券商承销佣金及保荐费 2,800.00 万元(不含 ...

重要内容提示： 浙江新农化工股份有限公司（以下简称"公司"）已于 2025 年 8 月 27 日在 公司指定信息披露媒体《证券时报》和巨潮资讯网（www.cninfo.com.cn）上披 露《2025 年半年度报告》及其摘要。为便于广大投资者更深入、全面地了解公 司的经营业绩、发展战略等情况，公司定于 2025 年 9 月 2 日（星期二）15:30-17:00 采用网络方式举办 2025 年半年度网上业绩说明会，与投资者进行沟通和交流， 具体情况如下： 会议召开时间：2025 年 9 月 2 日（星期二）15:30-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集：投资者可于 2025 年 9 月 2 日前使用微信扫描下方小程序码 或访问网址 https://eseb.cn/1qRSnqfihVe 进行会前提问，公司将通过本次业绩 说明会，在信息披露允许范围内就投资者普遍关注的问题进行回答。 一、说明会召开的时间、地点和方式 会议召开时间：2025 年 9 月 2 日（星期二）15:30-17:00 会议召开地点：价值在线（www.ir-onl ...

浙江新农化工股份有限公司 2025 年半年度财务报告 浙江新农化工股份有限公司 2025 年半年度财务报告 2025 年 8 月 1 | | | | 一、审计报告 3 | | --- | | 二、财务报表 3 | | 三、公司基本情况 22 | | 四、财务报表的编制基础 23 | | 五、重要会计政策及会计估计 23 | | 六、税项 61 | | 七、合并财务报表项目注释 62 | | 八、研发支出 103 | | 九、合并范围的变更 104 | | 十、在其他主体中的权益 104 | | 十一、政府补助 104 | | 十二、与金融工具相关的风险 105 | | 十三、公允价值的披露 110 | | 十四、关联方及关联交易 112 | | 十五、股份支付 114 | | 十六、承诺及或有事项 115 | | 十七、资产负债表日后事项 116 | | 十八、其他重要事项 116 | | 十九、母公司财务报表主要项目注释 116 | | 二十、补充资料 123 | 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：浙江新农 ...

| 其它关联资金往来 | 资金往来方名称 | 往来方与上 市公司的关 | 上市公司 核算的会 | 2025 年期初占 用资金余额 | 2025 年 用累计发生金额 | 1-6 月占 | 2025 | 年 1-6 占用资金的利 | 月 2025 | 年 偿还累计发 | 1-6 月 | 2025 期末占用资 | 年 6 月 | 往来形 成原因 | 往来性质(经营 性往来、非经营 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 联关系 | 计科目 | | (不含利息) | | | 息(如有) | | 生金额 | | 金余额 | | | 性往来) | | 控股股东、实际控 制人及其附属企业 | - | - | - | - | | - | | | - | | - | | - | - | - | | | - | - | - | - | | - | | | - | | - | | - | - | - | | | 江苏新农化工有限公司 | 子公司 | 其他应收款 ...

浙江新农化工股份有限公司 第七届董事会第二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江新农化工股份有限公司（以下简称"公司"）第七届董事会第二次会议 通知于 2025 年 8 月 15 日以电子邮件、电话等方式向公司全体董事发出。会议于 2025 年 8 月 26 日在公司会议室以现场结合通讯方式召开。本次会议由公司董事 长徐群辉先生主持，应出席会议董事 9 名，实际出席会议董事 9 名。 本次会议的召集、召开及表决程序符合有关法律、行政法规、部门规章、规 范性文件及《公司章程》的规定。 证券代码：002942 证券简称：新农股份 公告编号：2025-046 二、董事会会议审议情况 （一）审议通过《2025 年半年度报告》及其摘要 公司已严格按照相关法律、法规及中国证监会的规定，根据公司 2025 年半 年度实际经营情况编制了公司《2025 年半年度报告》及其摘要，报告内容真实、 准确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重 大遗漏。该议案经董事会审计委员会审议通过后提交董事会审议。《2 ...

光大证券股份有限公司 关于浙江新农化工股份有限公司 2025 年半年度募集资金存放与使用情况的专项核查报告 根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市公司自律监 管指引第 13 号——保荐业务》等法律法规的相关规定，光大证券股份有限公司 （以下简称"光大证券"或"保荐机构"）作为浙江新农化工股份有限公司（以 下简称"新农股份"或"公司"）的保荐机构，持续督导期至 2020 年 12 月 31 日止。截至 2024 年 12 月 31 日，公司首次公开发行股票募集资金尚未使用完毕， 公司于 2025 年 6 月完成剩余募集资金专用账户的销户工作，根据相关规定，光 大证券对公司的募集资金使用履行持续督导职责。光大证券在认真审阅公司董事 会《浙江新农化工股份有限公司 2025 年半年度募集资金存放与使用情况的专项 报告》的基础上，现就其 2025 年半年度募集资金存放与使用情况核查如下： 一、募集资金基本情况 （一）首次公开发行实际募集资金金额、资金到位时间 公司经中国证券监督管理委员会证监发行字[2018]1604 号文核准，由主承销 商光大证券通过深圳证券交易所系统采用网上按市值申购向社会公众投资 ...